Amarin seeks FDA nod to make Novasep a Vascepa API supplier

08/27/2013 | Pharmaceutical Business Review Online

Amarin filed a supplemental new-drug application with the FDA for approval to make Novasep an additional supplier of the active pharmaceutical ingredient for Vascepa, or icosapent ethyl. If approved, Novasep, through its subsidiary Finorga, would become the fourth supplier of the Vascepa's API.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA